Financial Consulate’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Financial Consulate's TAK Position: Q2 2026 in Review
Financial Consulate increased its Takeda Pharmaceutical (TAK) stake by 10% in Q2 2026, buying an estimated $4.43K and bringing the position to 2,908 shares worth $46.6K. The position accounts for 0.01% of the portfolio, ranked #361.
Financial Consulate first reported a position in TAK in Q3 2025 and has held it in 4 quarters since. The position peaked at $48.9K in Q1 2026. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.
- Financial Consulate held 2,908 shares of Takeda Pharmaceutical worth $46.6K as of Q2 2026.
- Financial Consulate bought 268 Takeda Pharmaceutical shares in Q2 2026, an estimated $4.43K.
- Takeda Pharmaceutical made up 0.01% of Financial Consulate's portfolio in Q2 2026, its #361 holding.
- Financial Consulate first reported a position in Takeda Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
- Financial Consulate's Takeda Pharmaceutical position peaked at $48.9K in Q1 2026.
- 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.
Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.